Difference between revisions of "Lanatoside C"

From Self-sufficiency
Jump to: navigation, search
m (Stub sorting and placement of stub template(s))
 
m (1 revision)
 
(No difference)

Latest revision as of 15:49, 19 September 2010

Lanatoside C
File:Isolanid.png
Systematic (IUPAC) name
(3β,5β,12β)- 3-{[β-D- glucopyranosyl- (1→4)- 3-O-acetyl- 2,6-dideoxy- β-D-ribo- hexopyranosyl- (1→4)- 2,6-dideoxy- β-D- ribo- hexopyranosyl- (1→4)- 2,6-dideoxy- β-D- ribo- hexopyranosyl]oxy}- 12,14-dihydroxycard- 20(22)- enolide
Identifiers
CAS Number 17575-22-3
ATC code C01AA06 (WHO)
PubChem CID 3879
Synonyms [6-[6-[6-[[12,14-dihydroxy- 10,13-dimethyl- 17-(5-oxo-2H-furan-3-yl)- 1,2,3,4,5,6,7,8,9,11,12,15,16,17- tetradecahydrocyclopenta[a]phenanthren- 3-yl]oxy]- 4-hydroxy- 2-methyloxan- 3-yl]oxy- 4-hydroxy- 2-methyloxan-3-yl]oxy- 2-methyl- 3-[3,4,5-trihydroxy- 6-(hydroxymethyl)oxan-2-yl]oxyoxan- 4-yl] acetate
Chemical data
Formula C49H76O20
Molar mass 985.116 g/mol[[Script error: No such module "String".]]
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Lanatoside C (or isolanid) is a cardiac glycoside, which can be used by the intravenous route. It is marketed as Cedilanide in Brazil by Novartis. Its main indications are rapid responde atrial fibrilation and paroxistic supraventricular tachycardia.